Sotalol Hydrochloride Tablet
Product Images NDC 71610-074
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sotalol Hydrochloride (NDC 71610-074). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Aphena Pharma Solutions (TN)
Figure1.jpg (Figure1)
This appears to be a table or graph comparing the recurrence-free survival of Sotalol Hydrochloride Tahlats (AF) versus a placebo at different doses. The results are presented using the Log-Rank method and values of 0.225, 0.012, and 0.029 are given for different doses. The X-axis appears to represent time in days. However, without additional context, it is not clear what condition or illness this analysis pertains to.*
Figure2.jpg (Figure2)
This is a graphical representation of Recurrence-Free Survival for patients taking Sotalol Hydrochloride Tablets (for Atrial Fibrillation) compared to Placebo. The graph shows the time in days (up to 180) on the X-axis and the percentage of patients who were recurrence-free on the Y-axis. A P-value of 0.002 was obtained using the Log-Rank test, suggesting that the use of Sotalol Hydrochloride Tablets has an effect on recurrence-free survival compared to Placebo.*
Structure (Sotalolhcl Af 01)
Age Factor (Sotalolhcl Af 04)
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.